Screening Of Adult urBan pOpulation To diAgnose Heart Failure
SOBOTA-HF
1 other identifier
observational
2,861
1 country
1
Brief Summary
Screening Of adult urBan pOpulation To diAgnose Heart Failure (SOBOTA-HF) is a cross-sectional prevalence study in a representative sample of Murska Sobota residents aged 55 years or more. Individuals will be invited to participate in a screening with NT-proBNP. All subjects with NT-proBNP ≥ 125 pg/mL will be invited for a diagnostic visit that will include history and physical examination, electrocardiogram, echocardiography, ankle brachial index, pulmonary function tests, body composition measurement, physical performance tests and questionnaires. To validate the screening procedure, a control group (NT-proBNP \< 125 pg/mL) will undergo same diagnostic evaluation. An external center will validate echodardiography exams and the HF diagnosis will be adjudicated within an independent HF expert panel. Overall and age specific HF prevalence will be calculated in individuals ≥ 55 years and extrapolated to the whole population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2017
CompletedFirst Submitted
Initial submission to the registry
May 4, 2018
CompletedFirst Posted
Study publicly available on registry
May 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2018
CompletedMay 16, 2018
May 1, 2018
1.1 years
May 4, 2018
May 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
heart failure diagnosis as per 2016 ESC guidelines
at diagnostic visit
Interventions
screening
Eligibility Criteria
60% of Murska Sobota residents aged 55 years or more
You may qualify if:
- age \>55
- living in Murska Sobota
- part of representative sample as selected by Statistical Office of the Republic of Slovenia
You may not qualify if:
- NONE.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- General Hospital Murska Sobotalead
- Roche Pharma AGcollaborator
- Slovenian Research Agencycollaborator
- Murska Sobota Municipialitycollaborator
- Community Health Center Murska Sobotacollaborator
Study Sites (1)
General Hospital Murska Sobota
Murska Sobota, SI-9000, Slovenia
Biospecimen
whole blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mitja Lainscak, MD, PhD
General Hospital Murska Sobota
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Internal Medicine
Study Record Dates
First Submitted
May 4, 2018
First Posted
May 16, 2018
Study Start
May 10, 2017
Primary Completion
June 30, 2018
Study Completion
September 30, 2018
Last Updated
May 16, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share